On this page
- What endocrinology billing involves
- Who this affects
- Diabetes visit coding and diagnosis specificity
- E/M levels and modifier 25
- Diabetes self-management training and nutrition therapy
- Continuous glucose monitoring: professional versus therapeutic
- Checks for professional CGM claims
- Insulin pumps and DME rules
- Thyroid biopsy, ultrasound, and related procedures
- In-office labs and CLIA
- Remote patient monitoring and chronic care management
- Remote patient monitoring
- Chronic care management and related codes
- Prior authorization for GLP-1 drugs and devices
- Common denial causes in endocrinology
- Investigation and correction workflow
- Hypothetical example: unbilled monthly services
- How Mednex works with endocrinology practices
- Mednex and practice responsibilities
- Records and access needed
- Quality checks and exceptions
- How progress is measured
- What cannot be promised
- Next steps
What endocrinology billing involves
Endocrinology is mostly cognitive, longitudinal care. Revenue comes from evaluation and management (E/M) visits, but a large share of the practice’s value sits in services that are easy to miss: device interpretation, point-of-care testing, procedures, patient education, and monthly programs billed by time. A practice that bills only the office visit leaves those services unreported. A practice that bills them without matching documentation invites denials and audits.
The billing work falls into five streams:
- Visits and diagnosis coding. E/M levels, ICD-10-CM specificity for diabetes, thyroid, adrenal, pituitary, and metabolic bone disease, and modifier 25 when a visit and a procedure happen on the same day.
- Devices and supplies. Professional CGM services billed by the practice, and therapeutic CGM and insulin pumps billed by a supplier under durable medical equipment (DME) rules, with the practice supplying the order and the visit documentation.
- Procedures and testing. Thyroid fine needle aspiration, thyroid and neck ultrasound, bone density testing, and in-office labs covered by CLIA rules.
- Time-based programs. Remote patient monitoring (RPM), chronic care management (CCM), principal care management, diabetes self-management training, and nutrition therapy.
- Drugs and authorizations. GLP-1 receptor agonists and other injectables handled through the pharmacy benefit, plus office-administered drugs for conditions such as osteoporosis that fall under the medical benefit.
The general claim workflow is described on the medical billing page. This page covers what changes for endocrinology.
Who this affects
- Solo and small-group endocrinologists who use one biller or a front-desk employee for every task
- Diabetes and metabolic practices that run education programs, CGM clinics, or nurse-led titration visits
- Practices that added RPM or CCM and are unsure whether the time logs would survive a payer review
- Thyroid-focused practices that perform in-office ultrasound and biopsy
- Primary care and internal medicine groups with a high diabetes panel that bill many of the same services
- Practices seeing a rise in prior authorization requests for injectables and devices
Diabetes visit coding and diagnosis specificity
Most denials in this specialty start with a diagnosis that does not support the service. The ICD-10-CM diabetes categories require the type, the presence of complications, and the control status where the classification asks for it. A claim coded with a general, unspecified diabetes code may be accepted by one payer and denied by another that ties a device or lab to a specific diagnosis.
Points the billing team should check on every diabetes encounter:
- Complication linkage. The classification lets coders report diabetes with a complication when the provider documents the relationship, and several conditions are presumed related under the guidelines. The provider’s note should state the link rather than leave the coder to infer it.
- Long-term medication status. The Z79 codes record long-term insulin use, long-term oral hypoglycemics, and long-term injectable non-insulin antidiabetic drugs. Payers that cover a device or drug for insulin-treated patients often look for the insulin status on the claim.
- Hyperglycemia and hypoglycemia. Codes for these conditions are separate from the base diabetes code. Documentation that supports problematic hypoglycemia matters for CGM coverage.
- Other endocrine diagnoses. Thyroid nodules, hypothyroidism, hyperthyroidism, adrenal and pituitary disorders, and osteoporosis each have their own coding conventions. Use the current ICD-10-CM guidelines and the provider’s documented words, not shorthand from the problem list.
E/M levels and modifier 25
Office visits are leveled by medical decision making or total time on the date of the encounter. Endocrinology notes often carry heavy data review, such as reviewing glucose logs, labs, and imaging, and the level should reflect work that is documented. When a procedure or a separately reportable service happens the same day, the E/M needs a modifier 25 and a note that shows the visit was significant and separately identifiable from the procedure. A routine pre-procedure check does not support a second charge. The medical billing modifiers guide explains modifier logic in more detail.
Diabetes self-management training and nutrition therapy
Medicare uses HCPCS codes G0108 and G0109 for individual and group diabetes self-management training (DSMT), and CPT codes 97802 to 97804 or HCPCS G0270 for medical nutrition therapy (MNT). These services depend on a referral, a qualifying program or provider, and often on the payer’s frequency and hour limits. Many commercial plans follow their own rules. If the practice runs an education program, confirm program accreditation or recognition requirements, who may render the service, and whether the plan lets the service be billed on the same day as an E/M.
Continuous glucose monitoring: professional versus therapeutic
CGM creates two separate billing situations, and mixing them up is a common cause of denial.
| Situation | Who bills | What is billed | Common problem |
|---|---|---|---|
| Professional CGM (clinic-owned sensor or receiver worn for a short period) | The practice | CPT 95250 for sensor placement, hook-up, and data download with patient training; 95251 for interpretation and report; 95249 when the patient owns the equipment | Interpretation billed with no recorded report, or billed more often than the payer allows |
| Therapeutic CGM (patient uses it daily at home) | A DME supplier, under the DME benefit | HCPCS receiver and supply allowance codes such as E2102, A4238, and A4239 on Medicare claims | Supplier denied because the prescribing visit documentation does not meet policy |
For Medicare therapeutic CGM, the CMS compliance guidance lists the elements the record needs: a diabetes diagnosis, a prescription confirming the patient or caregiver has enough training to use the device and that it is prescribed for an FDA-indicated use, a purpose of improving glycemic control, and either insulin treatment or a history of problematic hypoglycemia. It also requires an in-person or Medicare-approved telehealth visit within six months before the order and follow-up visits at least every six months to confirm continued need and adherence. The practice does not usually bill the supplier’s claim, but the supplier’s payment depends on the practice’s note. A supplier that is denied or recouped will often return to the clinic for corrected records.
Commercial plans may use different criteria, may require prior authorization, and may route CGM through the pharmacy benefit instead of DME. Verification should identify which benefit applies before the order is written.
Checks for professional CGM claims
- Confirm the plan covers professional CGM and how often.
- Confirm the recording period meets the code’s minimum wear time. Short or failed recordings do not support the interpretation code.
- Make sure a signed interpretation and report exists in the chart, written by the provider, not just a downloaded printout.
- Check that placement and interpretation are not reported by the wrong provider type under the plan’s rules.
- Check whether the plan treats the service as bundled with a same-day E/M or with another monitoring code.
Insulin pumps and DME rules
External insulin pumps are paid under different rules depending on the pump type and the payer. Tubed pumps are generally handled as durable medical equipment, with supplies billed separately. Some patch-style pumps are handled through the pharmacy benefit instead. The pump category decides the benefit, the supplier, the prior authorization pathway, and the documentation request.
What the practice owns in a pump start:
- The order and the clinical documentation of diabetes type, insulin regimen, glucose monitoring frequency, and the reason the patient needs pump therapy
- Any payer-required evidence, such as lab values, prior education, or a documented trial of other regimens, according to the payer’s own policy
- Follow-up visits that plans often require to continue paying for supplies
- The E/M and training time for pump initiation, if the plan pays for it as a separate visit
What the supplier owns is the equipment claim, delivery proof, and supply refills. If the practice dispenses equipment itself, it needs the right enrollment as a DME supplier with each payer, which is a different process from physician enrollment. That is a credentialing question, not a coding one, and it should be settled before the first device ships.
For devices, the usual failure is sequence. If the supplier ships before the qualifying visit is documented, or the visit falls outside the payer’s look-back window, the supplier claim can be denied or recouped. The practice should confirm the visit date against the policy window before it signs the order.
Thyroid biopsy, ultrasound, and related procedures
Thyroid work is where endocrinology billing looks most like procedural specialties. The common code families are:
- Fine needle aspiration (FNA). CPT 10005 reports FNA with imaging guidance for the first lesion, and 10006 reports each additional lesion. CPT 10021 reports FNA without imaging guidance. Because the 10005 family includes imaging guidance, the guidance should not be billed again as a separate line.
- Core needle biopsy of the thyroid. CPT 60100 reports a percutaneous core biopsy. Payers differ on how it relates to FNA when both are performed.
- Diagnostic ultrasound. CPT 76536 reports soft tissue ultrasound of the head and neck, which includes the thyroid. A diagnostic study needs a permanent image record and a written report. If a diagnostic ultrasound and a guided FNA both occur, the note should show that the diagnostic study was separately indicated and is not the same imaging used for guidance. Check the NCCI edits for the date of service.
- Cytology. Pathologists bill their own interpretation. If the practice provides on-site adequacy evaluation, check which codes apply and who may bill them.
Ultrasound can be billed as global (equipment plus interpretation), or split into professional and technical components when a hospital or a separate entity owns the equipment. The same idea is discussed on the radiology billing page. For endocrinology groups that own their equipment and read their own studies, global billing is common, but the ultrasound room needs a protocol, saved images, and a signed report.
Other procedures that appear in some endocrine practices include bone density testing (CPT 77080 for axial DXA, with frequency limits that vary by payer) and office-administered osteoporosis drugs billed with HCPCS J-codes, such as denosumab and zoledronic acid. Drug claims need the correct billing units, the drug code that matches the product, and in many cases a prior authorization. The J-codes explainer covers how units and drug codes work.
In-office labs and CLIA
Many endocrinology practices run point-of-care tests, especially hemoglobin A1c and glucose. Three rules matter:
- CLIA certificate. The practice needs the right CLIA certificate for the complexity of the tests it performs, such as a certificate of waiver for waived tests. The number must be on the claim when required.
- QW modifier. Medicare and some other payers require modifier QW on CLIA-waived tests that appear on their list. Missing QW is a simple, preventable denial. Check each payer’s list, because it changes.
- Frequency and diagnosis edits. Payers limit how often A1c and similar tests can be paid and may require a matching diagnosis. A repeat test inside the window is denied unless the record supports the need.
Send-out labs are billed by the laboratory, not the practice. If the practice draws blood only, the collection fee is the usual practice charge, and the lab bills the test. Do not report a send-out test under the practice’s NPI.
Remote patient monitoring and chronic care management
RPM and CCM are the most audit-sensitive services in the specialty because they are paid on time, data, and consent, not on a single visit.
Remote patient monitoring
RPM for glucose or blood pressure monitoring uses separate codes for device setup, device supply with data transmission, and clinical management time. The established structure includes CPT 99453 for setup and education, 99454 for the device supply and data transmission period, 99457 for the first block of interactive management time in a calendar month, and 99458 for each added block. For 2026, CMS added shorter-period codes: 99445 for device supply when data are transmitted on only 2 to 15 days in a 30-day period, and 99470 for a shorter first block of management time. Whether a given commercial plan accepts the new codes, or still follows the older day and minute thresholds, needs to be checked plan by plan.
RPM claims fail on the following points:
- No documented patient consent or no documented establishment of the patient relationship where the payer requires it
- Device not a medical device that digitally transmits the reading
- Too few days of transmitted data in the billing period
- Management time that cannot be tied to a named staff member, a date, and an activity
- Overlap with other care-management services billed for the same month, where the payer disallows both
Chronic care management and related codes
CCM uses time-based codes that distinguish clinical staff time from complex management and physician time. Patients need qualifying chronic conditions, a documented care plan, consent, and 24 hour access arrangements. Only one practitioner can generally bill CCM for a patient in a month, which matters when the patient also sees primary care. Principal care management codes serve a similar role for a single high-risk condition and are billed with their own rules. Confirm with each payer which codes it recognizes, whether it requires a face-to-face visit within a set period, and whether it will pay CCM and RPM in the same month.
Prior authorization for GLP-1 drugs and devices
Authorization work in endocrinology splits in two. GLP-1 receptor agonists and other self-administered injectables usually run through the pharmacy benefit, where the pharmacy benefit manager (PBM) sets the criteria. Devices, imaging, and office-administered drugs run through the medical benefit.
Typical pharmacy-benefit requirements include a confirmed diagnosis, recent A1c or other lab values, documentation of prior therapy such as metformin or other first-line options, and sometimes step therapy. Coverage for weight-management use is separate from coverage for type 2 diabetes, and both federal program policy and individual plans for weight-management drugs have been changing, so the indication on the order and the payer’s current formulary are the facts to confirm. A request that cites the wrong indication can be denied even when the patient qualifies for a different one.
A workable authorization process has these parts:
- Verify the pharmacy and medical benefits and identify which one covers the item.
- Collect the payer’s criteria before the order, not after the denial.
- Submit with the labs, notes, and prior therapy dates the criteria ask for.
- Log the reference number, decision date, approved quantity, and expiry.
- Schedule the renewal before the authorization lapses.
- For a denial, read the stated reason, decide between peer-to-peer, formal appeal, or an alternative regimen, and keep the patient informed.
The prior authorization services page describes how Mednex supports this process, and the prior authorization explainer covers the basics. An approval is not a guarantee of payment, and some plans can still review a claim after the fact.
Common denial causes in endocrinology
| Denial pattern | Likely cause | Fix |
|---|---|---|
| Procedure or test not medically necessary | Diagnosis does not match the payer’s covered list; unspecified diabetes code used | Review the note, code to the documented specificity, resubmit with the supporting diagnosis |
| E/M denied as bundled with procedure | Modifier 25 missing or the note does not show a separate service | Add modifier 25 only if the note supports it; appeal with the relevant section of the note |
| CGM interpretation denied | Frequency limit, short recording period, or no signed report | Check the plan’s limit; attach the report; correct if the wrong code was used |
| A1c or glucose test denied | QW missing, CLIA number missing, or repeat inside the frequency window | Add the modifier and certificate where valid; request reconsideration with clinical reason for repeat |
| RPM or CCM denied | Insufficient days or minutes, missing consent, overlapping service | Compare logs with the plan’s thresholds; rebill if the record supports it; stop billing what it does not |
| Drug claim denied | No prior authorization, wrong units, or wrong drug code | Confirm the authorization, recalculate units from the drug’s billing unit, correct and resubmit |
| Device supplier recoupment | Qualifying visit outside the window or missing prescription elements | Provide the compliant records if they exist; fix the order workflow going forward |
The denial overview and the rejection versus denial guide explain how to read the payer’s reason codes.
Investigation and correction workflow
When endocrinology claims drop or stall, work through the following steps in order.
- Problem. Define what is wrong: a rising denial rate for one code, unpaid RPM claims, aging drug claims, or a gap between visits and charges.
- Evidence to inspect. Pull the denial and remittance report, A/R aging by payer, charge-to-visit reconciliation, and a sample of the related notes. Include the explanation of benefits or electronic remittance details for exact reason and remark codes.
- Likely causes. Group the problems into eligibility, authorization, coding, documentation, payer policy change, or submission error. Most clusters have one dominant cause.
- Investigation steps. Check a few claims in each group against the payer policy, the provider note, and the claim as sent. Confirm whether the same issue appears across providers.
- Corrective action. Fix the root cause: a template that omits the CGM interpretation statement, a missing QW edit in the billing system, an authorization tracker without renewal dates.
- Submission and follow-up. Resubmit or appeal affected claims within the payer’s deadlines, which vary by payer and contract, and follow up on a schedule. The denial management page covers this stage.
- Prevention. Add front-end checks, claim scrubber rules, and provider feedback so the same error does not return.
- Measurement. Track whether the error category shrinks over the next billing cycles.
Hypothetical example: unbilled monthly services
Hypothetical example. The numbers below are illustrations, not data from any practice. A small endocrinology group enrolls patients in RPM for glucose readings. Clinical staff review readings and call patients, but the minutes are written in free-text notes, and no one totals them each month. Billing sees the enrollment but cannot tell which patients crossed the plan’s minute threshold, so it bills only the device code for everyone. Suppose 100 patients are enrolled, the group bills the device code for all of them, and a review shows that about 60 had enough documented time to support the management code too. The group has been leaving unreported work off the claim, while the device claims for a handful of patients with too few transmission days may be at risk if audited. The fix is a monthly log with patient, date, staff member, minutes, and activity, a report that totals minutes and transmission days per patient, and a billing rule that releases each code only when the threshold is documented. The same approach applies to CCM.
How Mednex works with endocrinology practices
Mednex Group handles billing as a defined process. Scope depends on your software, payers, and volume, and is confirmed in writing before work starts.
- Verify eligibility and benefits for visits, devices, labs, and drugs, and note which benefit pathway applies.
- Review charges against notes for procedure, device, RPM, and CCM documentation and flag gaps for provider review.
- Prepare and submit claims with correct modifiers and diagnosis linkage.
- Track prior authorizations and renewals, and work denials and appeals.
- Post payments, reconcile remittances, and follow up on aging A/R.
- Report on denial reasons, aging by payer, and charge capture gaps.
Mednex and practice responsibilities
| Area | Mednex | Practice |
|---|---|---|
| Clinical decisions and documentation | Flags gaps and asks questions | Writes the note, signs reports, decides treatment |
| Coding | Applies codes to documentation and payer rules; queries when unclear | Confirms the final code when documentation is ambiguous |
| RPM and CCM logs | Checks logs against thresholds before billing | Records consent, time, and activity accurately |
| Authorizations | Submits, tracks, and reminds on renewals | Supplies clinical information and takes part in peer-to-peer reviews |
| Device orders | Checks payer criteria and visit windows | Signs orders and manages supplier relationships |
| Compliance | Follows agreed workflows | Owns the compliance program and final billing decisions |
Records and access needed
- Practice management and EHR access, using the method agreed in writing
- Payer list, fee schedules or contracts where available, and enrollment details
- A/R aging, denial and remittance reports, and recent charge reports
- CLIA certificate details and the list of tests performed in-house
- RPM and CCM logs, consent forms, and care plan templates
- Current authorization log and device supplier list
Patient information moves only under a signed business associate agreement and through a secure workflow. Never send patient records through the website form.
Quality checks and exceptions
- Pre-bill check that every procedure, interpretation, and time-based code has the document that supports it
- Edit for modifier 25, QW, and RT or LT where relevant
- Exception queue for claims that fail payer-specific rules, reviewed by a person
- Monthly review of RPM and CCM totals before submission
- Authorization expiry list checked weekly
- Escalation of unusual denial patterns to the practice, not silent resubmission
Exceptions include patients with coverage changes mid-month, devices changed under a warranty, and secondary insurance that handles an item differently. These cases are handled one claim at a time.
How progress is measured
Useful measures for endocrinology include clean claim rate, denial rate by code and payer, days in A/R, A/R older than 90 days, authorization turnaround and expiry misses, RPM and CCM claims paid versus submitted, and charge capture compared with scheduled visits and procedures. The clean claim rate and days in A/R guide defines the first two. Baselines should come from your own data before any change, and reports should compare like periods. The revenue cycle management page describes the broader reporting picture.
What cannot be promised
Mednex cannot guarantee reimbursement, payer decisions, authorization approvals, appeal outcomes, or coverage for a specific device or drug. Payers set their own policies and can change them. Mednex also does not make clinical documentation judgments, provide legal advice, or negotiate payer contracts.
Next steps
A good first step is a review of your own data. The Free Medical Billing Audit looks at a sample of recent claims, denial reasons, A/R aging by payer, and charge capture gaps, and ends with a written summary and a walkthrough call. You can also see the broader specialty billing pages, or reach the team through the contact page. If you want to start with a view of where RPM, CGM, and drug claims are stuck, ask for those categories to be included in the sample. Request the audit when you are ready.
Frequently asked questions
What do endocrinology billing services include?
They cover eligibility and benefit checks, charge review against the visit note, claim submission with the right modifiers, prior authorization tracking, denial and appeal work, payment posting, and A/R follow-up. For endocrinology that also means checking CGM, RPM, CCM, thyroid procedure, and in-office lab documentation before a claim goes out. The practice remains responsible for clinical notes, signed reports, and treatment decisions, and Mednex does not promise payer outcomes. In practice the first step is a baseline review of recent denials and aging by payer, so the team knows whether the problem sits in coding, authorization, or follow-up before it changes any workflow.
How is CGM billed in an endocrinology practice?
There are two paths. Professional CGM uses a clinic-owned device worn for a short period, and the practice bills placement and interpretation codes such as 95250 and 95251, or 95249 when the patient owns the equipment. Therapeutic CGM for daily home use is normally billed by a DME supplier, and the practice supports it with an order and visit documentation. Benefit routing and criteria differ by payer, so verify which path applies before the order is written. For a new patient start, a short checklist helps: the diagnosis, the device type, who supplies it, and which visit date the payer will see. Confirm it before the order leaves the office.
What does Medicare require for therapeutic CGM coverage?
CMS guidance describes a diabetes diagnosis, a prescription showing the patient or caregiver is trained to use the device for an FDA-indicated use, a goal of improving glycemic control, and either insulin treatment or documented problematic hypoglycemia. An in-person or approved telehealth visit is needed within six months before the order and about every six months afterward. Policies are revised, so confirm current rules with your DME MAC and keep the visit dates easy to find. A common trap is a visit that happened more than six months before the order, or a note that never states the training. Add a recurring reminder tied to each patient's last qualifying visit.
Can an endocrinologist bill an office visit and a thyroid biopsy on the same day?
Sometimes. A fine needle aspiration such as CPT 10005 can be reported with an E/M when the visit is significant and separately identifiable, which usually means modifier 25 and a note that shows the extra work. A routine check before the procedure does not support a second charge. Payer edits differ and NCCI bundling rules apply, so check the date of service against current edits and keep the visit note and procedure note distinct. Hypothetical example: a note records a thyroid nodule check and a biopsy, but only one signed note exists. Splitting the evaluation from the procedure in the note makes the second charge defensible.
Why are remote patient monitoring claims denied?
The most common reasons are too few days of transmitted data, management minutes that cannot be traced to a staff member and date, missing patient consent, a device that does not qualify, and overlap with another care-management code in the same month. Plans also differ on the newer 2026 codes. Keep a monthly log with patient, date, minutes, and activity, and check each plan's thresholds before releasing the claim. Remote monitoring also needs a fixed monthly cutoff. If staff review minutes after the claim has gone out, the time is lost, so set the log review date before submission.
Why do GLP-1 prior authorizations get denied?
Frequent causes are an indication that does not match the plan's covered use, missing A1c or other lab values, no record of required first-line therapy, and a request sent to the wrong benefit. Weight-management coverage differs from type 2 diabetes coverage and has been changing. Read the plan's criteria first, attach the exact records it asks for, and track the approval's expiry date so renewals do not lapse. Appeals work better when the letter lists each criterion with the page of the record that meets it. Track the approval end date, and prepare the renewal packet a few weeks ahead.
Do I need the QW modifier on in-office A1c tests?
Many payers, including Medicare, require QW on CLIA-waived tests that appear on their list, and a missing modifier is an easy denial. The claim also needs the right CLIA certificate, and the number must appear where the payer asks for it. Payers update their lists and frequency limits, so check each plan's current policy and set a billing system edit rather than relying on staff memory. If your lab runs several waived tests, build a table of code, modifier, and frequency limit per payer. A billing system edit that adds QW automatically removes dependence on memory.
Can a small endocrinology practice benefit from outsourced billing?
A small practice often has one person handling eligibility, coding, authorizations, and denials, which leaves time-based services like RPM and CCM unchecked. Outsourcing can add structure and reporting, but it does not replace the practice's own documentation. Compare options using your own A/R and denial data. The Free Medical Billing Audit is a way to see that data and a written summary before you decide anything. A reasonable test is whether the practice's own documentation habits are sound. Outsourcing does not fix missing notes. Start with a written list of what each side does each week, so nothing falls between them.
How is pricing set for endocrinology billing services?
Pricing depends on claim volume, which tasks are included, and the number of providers and payers. Mednex does not publish rates on this page. Ask any billing company for the pricing model in writing, including what is extra, such as authorizations, patient statements, or old A/R work, and how the fee changes as volume changes. Compare quotes on the same scope so the numbers mean the same thing. Ask also who owns the clearinghouse and payer portal accounts, what reports the practice receives and how often, and what happens to open claims if the contract ends. These terms matter as much as the rate.
Sources
- CMS MLN: Glucose Monitoring Supplies (Medicare provider compliance tips)
- Physicians Practice: 2026 Physician Fee Schedule final rule, RPM and remote care
- CMS: JW Modifier FAQs (drug billing context)
Payer rules vary by payer, plan, state and contract. Check the current policy before acting.